Jefferies analyst Brian Tanquilut downgraded Oak Street Health (OSH) to Hold from Buy with a price target of $39, up from $36, after CVS Health (CVS) announced a definitive agreement to acquire the company for $39 per share in an all-cash transaction. Given that a month has passed since the pending deal was first reported in the press, the analyst does not expect competing bids to emerge at this point.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on OSH:
- Oak Street Health downgraded to Market Perform from Outperform at William Blair
- Oak Street Health downgraded to Hold from Buy at Canaccord
- Oak Street Health downgraded to Hold from Buy at Truist
- CVS Health says Oak Street Health deal has long term growth, earnings power
- Oak Street Health downgraded to In Line from Outperform at Evercore ISI